G
2.22
-0.04 (-1.77%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Grace Therapeutics, Inc. | Mixed | Mixed |
AIStockmoo Score
2.5
| Analyst Consensus | NA |
| Insider Activity | 2.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 2.0 |
| Average | 2.50 |
|
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 28.15% |
| % Held by Institutions | 29.14% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Maven Securities Ltd | 30 Jun 2026 | 200,000 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| KOHLI PRASHANT | 2.14 | - | 100,000 | 214,000 |
| OPALEYE MANAGEMENT INC. | 2.13 | - | 15,229 | 32,402 |
| Aggregate Net Quantity | 115,229 | |||
| Aggregate Net Value ($) | 246,402 | |||
| Aggregate Avg. Buy ($) | 2.13 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| KOHLI PRASHANT | Officer | 09 Sep 2026 | Buy (+) | 100,000 | 2.14 | 214,000 |
| OPALEYE MANAGEMENT INC. | 09 Sep 2026 | Buy (+) | 5,836 | 2.14 | 12,489 | |
| OPALEYE MANAGEMENT INC. | 08 Sep 2026 | Buy (+) | 9,393 | 2.12 | 19,913 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |